SUBSCRIBE
SUBSCRIBE
News   FDA

FDA Clears Potential Johnson & Johnson Blockbuster Arthritis Drug

April 24, 2009 | 
1 min read
AP -- The Food and Drug Administration has approved a potential blockbuster drug from Johnson & Johnson that fights three forms of arthritis caused by immune-system deficiencies.
FDA Approvals
Johnson & Johnson Family of Companies Food and Drug Administration (FDA)
MORE ON THIS TOPIC
Podcast
China Crackdown, UK Exit, Novo Layoffs, Adcomm Flip Flop, More
September 17, 2025
 · 
2 min read
 · 
Heather McKenzie
man pulling each of the opposite ends of a rope in black and white, on a blue background with some blank space on top
Obesity
Novo, Lilly Jostle For Market Lead in Obesity With New Regulatory Efforts
September 16, 2025
 · 
2 min read
 · 
Tristan Manalac
Hanging questions.Blue background.
Adcomms
FDA Flip-Flops on Scrapping Adcomms
September 15, 2025
 · 
2 min read
 · 
Tristan Manalac
A scientist with pill bottles in front of FDA headquarters
FDA
FDA Action Alert: Merck, Sanofi, Biogen and More
September 15, 2025
 · 
6 min read
 · 
Tristan Manalac